You are here

  • Home
  • Archive
  • Volume 7, Issue Suppl 1
  • O-024 the ace study multicenter experience: safety and effectiveness of using large volume penumbra pc400 coil and 0.025” microcatheter in treating anterior communicating artery aneurysms

Article Text

Article menu

Download PDFPDF

Oral abstracts
SNIS 12th Annual Meeting Oral Abstracts
O-024 the ace study multicenter experience: safety and effectiveness of using large volume penumbra pc400 coil and 0.025” microcatheter in treating anterior communicating artery aneurysms
  1. B Baxter1,
  2. O Zaidat2,
  3. E Deshaies3,
  4. M Kabbani4,
  5. J Lynch2,
  6. D Lopes5,
  7. A Turk6,
  8. C Roth7,
  9. A Chowdhary8,
  10. G Rappard9,
  11. M Knauth10,
  12. P Schramm10,
  13. F Hui11,
  14. M Ollenschleger12,
  15. J Jacobson13,
  16. A Shhadeh14,
  17. R Pergolizzi15,
  18. S Prothmann16,
  19. A Khaldi17,
  20. E Luong18,
  21. S Hak18,
  22. S Kuo18,
  23. N Nguyen18,
  24. D Ueda18,
  25. S Sit18
  1. 1Erlanger Health System, Chattanooga, TN, USA
  2. 2Froedtert Hospital, Milwaukee, WI, USA
  3. 3SUNY Upstate Medical Center, Syracuse, NY, USA
  4. 4Gundersen Lutheran Hospital, La Crosse, WI, USA
  5. 5Rush University Medical Center, Chicago, IL, USA
  6. 6Medical University of South Carolina, Charleston, SC, USA
  7. 7Klinikum Bremen-Mitte, Bremen, Germany
  8. 8Overlake Hospital Medical Center, Bellevue, WA, USA
  9. 9Los Angeles Brain and Spine Institute, Los Angeles, CA, USA
  10. 10University Medical Center Göttingen, Göttingen, Germany
  11. 11Cleveland Clinic, Cleveland, OH, USA
  12. 12Hartford Hospital, Hartford, CT, USA
  13. 13Loma Linda University Adventist Health Sciences Center, Loma Linda, CA, USA
  14. 14Aurora St. Luke's Medical Center, Milwaukee, WI, USA
  15. 15Inova Fairfax Hospital, Falls Church, VA, USA
  16. 16Technical University of Munich, München, Germany
  17. 17WellStar Kennestone Hospital, Marietta, GA, USA
  18. 18Penumbra, Inc., Alameda, CA, USA

Abstract

Purpose The utility of the Penumbra Coil 400 (PC400) System in embolization of aneurysms in smaller caliber arteries has yet to be characterized. The goal was to assess the safety and effectiveness of the PC400 with the use of the 0.025” ID PXSLIM microcatheter in the anterior communicating artery. Reported herein are the initial clinical experience and long-term results in a subset of the Aneurysm Coiling Efficiency (ACE) registry. Results from conventional coils published in peer-reviewed journals are used as historical controls.

Methods Our treatment cohort consisted of 46 aneurysms ranging between 3.5–17 mm in diameter. Patients were treated between March 2012–January 2015 at 16 high volume centers. Six-month follow-up data were assessed. Data on angiographic results and procedural complications were collected prospectively and analyzed.

Results The mean aneurysm size was 6.3 ± 2.8 mm, 22 ruptured and 24 unruptured. All aneurysms were treated entirely with PC400 coils, with a mean of 5.0 ± 3.5 coils placed. Sixty-two percent of the cases achieved an initial Raymond Scale of 1, and 28.9% achieved a Raymond scale of 2 post-procedure. Mean packing density was 38.8%±18.5 at immediate post-procedure.

The rate of retreatment at 6 months was 0%, while the overall rate of morbidity/mortality caused by stroke at 30 days was 6.5%. Comparison with a recently published meta-analysis of conventional coils showed similar or superior outcomes with lower procedural complication rates, most notably lower overall vasospasm rate of 4% vs. 13%, permanent procedure-related morbidity rate of 2% vs. 6%, lower retreatment rate of 0% vs. 7% and higher long-term (6 months or more) complete and near-complete occlusion of 96% vs. 85% with PC400 coils (Tables 1, 2).

Abstract O-024 Table 1
Abstract O-024 Table 1

Angiographic outcome rates

Abstract O-024 Table 2
Abstract O-024 Table 2

Ruptured vs. ruptured rates

Conclusion Initial multicenter experience demonstrates that embolization using the PC400 System and 0.025” ID PXSLIM microcatheter in the small caliber vessel AcomA aneurysms leads to safe and effective short- and long-term outcomes.

Disclosures B. Baxter: None. O. Zaidat: None. E. Deshaies: None. M. Kabbani: None. J. Lynch: None. D. Lopes: 4; C; Penumbra, Inc.. A. Turk: None. C. Roth: None. A. Chowdhary: None. G. Rappard: None. M. Knauth: None. P. Schramm: None. F. Hui: None. M. Ollenschleger: None. J. Jacobson:  None. A. Shhadeh: None. R. Pergolizzi: None. S. Prothmann: None. A. Khaldi: None. E. Luong: 5; C; Penumbra, Inc. S. Hak: 5; C; Penumbra, Inc. S. Kuo: 5; C; Penumbra, Inc. N. Nguyen: 5; C; Penumbra, Inc. D. Ueda: 5; C; Penumbra, Inc. S. Sit: 4; C; Penumbra, Inc. 5; C; Penumbra, Inc.

https://doi.org/10.1136/neurintsurg-2015-011917.24

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.